Lustra

— THERAPEUTIC CATEGORIES —
  • Pigmentation disorders

Lustra Generic Name & Formulations

General Description

Hydroquinone 4%; crm; contains sulfites.

Pharmacological Class

Depigmenting agent.

See Also

How Supplied

Crm—1oz, 2oz

Manufacturer

Lustra Indications

Indications

UV-induced skin dyschromia and discoloration due to hormonal changes or skin trauma.

Lustra Dosage and Administration

Adult

Apply to affected areas twice daily. Discontinue if lightening effect does not occur after 2 months.

Children

Not recommended.

Lustra Contraindications

Not Applicable

Lustra Boxed Warnings

Not Applicable

Lustra Warnings/Precautions

Warnings/Precautions

Do skin sensitivity test before use; do not use if itching, vesicle formation or excessive inflammation occurs. Avoid sun and UV light. Not for use as a sunscreen. Avoid eyes. Pregnancy (Cat.C). Nursing mothers.

Lustra Pharmacokinetics

See Literature

Lustra Interactions

Not Applicable

Lustra Adverse Reactions

Adverse Reactions

Contact dermatitis.

Lustra Clinical Trials

See Literature

Lustra Note

Not Applicable

Lustra Patient Counseling

See Literature